These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
43. Aligning policy to promote cascade genetic screening for prevention and early diagnosis of heritable diseases. George R; Kovak K; Cox SL J Genet Couns; 2015 Jun; 24(3):388-99. PubMed ID: 25577298 [TBL] [Abstract][Full Text] [Related]
44. [Hypercholesterolemia in children and young adults: should screening be done?]. Keller U Schweiz Med Wochenschr; 1995 Feb; 125(7):255-63. PubMed ID: 7878403 [TBL] [Abstract][Full Text] [Related]
45. Predictors of Family Enrollment in a Genetic Cascade Screening Program for Familial Hypercholesterolemia. Silva PRS; Jannes CE; Oliveira TGM; Gómez LMG; Krieger JE; Santos RD; Pereira AC Arq Bras Cardiol; 2018 Oct; 111(4):578-584. PubMed ID: 30156605 [TBL] [Abstract][Full Text] [Related]
47. Cost-effectiveness analysis of the genetic screening program for familial hypercholesterolemia in The Netherlands. Wonderling D; Umans-Eckenhausen MA; Marks D; Defesche JC; Kastelein JJ; Thorogood M Semin Vasc Med; 2004 Feb; 4(1):97-104. PubMed ID: 15199439 [TBL] [Abstract][Full Text] [Related]
48. What Should Be the Screening Strategy for Familial Hypercholesterolemia? McCrindle BW; Gidding SS N Engl J Med; 2016 Oct; 375(17):1685-1686. PubMed ID: 27783919 [No Abstract] [Full Text] [Related]
49. Documented need for more effective diagnosis and treatment of familial hypercholesterolemia according to data from 502 heterozygotes in Utah. Williams RR; Schumacher MC; Barlow GK; Hunt SC; Ware JL; Pratt M; Latham BD Am J Cardiol; 1993 Sep; 72(10):18D-24D. PubMed ID: 8213492 [TBL] [Abstract][Full Text] [Related]
50. [Familial hypercholesterolemia: why screening, counselling and treatment should be integrated]. Roeters van Lennep JE; Visseren FL; Jira PE Ned Tijdschr Geneeskd; 2015; 159():A8875. PubMed ID: 26013253 [TBL] [Abstract][Full Text] [Related]
51. [Screening of school children for familial hypercholesterolemia]. Jepsen BS; Micic S; Hansen B; Larsen SO; Pedersen BN; Skovby F Ugeskr Laeger; 1994 Mar; 156(13):1962-4. PubMed ID: 8009690 [TBL] [Abstract][Full Text] [Related]
53. Prevention of familial cardiovascular disease by screening for family history and lipids in youths. Williams RR; Hunt SC; Barlow GK; Wu LL; Hopkins PN; Schumacher MC; Hasstedt SJ; Ware J; Chamberlain RM; Weinberg AD Clin Chem; 1992 Aug; 38(8B Pt 2):1555-60. PubMed ID: 1643739 [TBL] [Abstract][Full Text] [Related]
54. Pediatric aspects of familial hypercholesterolemias: recommendations from the National Lipid Association Expert Panel on Familial Hypercholesterolemia. Daniels SR; Gidding SS; de Ferranti SD; J Clin Lipidol; 2011 Jun; 5(3 Suppl):S30-7. PubMed ID: 21600527 [No Abstract] [Full Text] [Related]
55. Prevalence of Familial Hypercholesterolemia in Adolescents: Potential Value of Universal Screening? Pang J; Martin AC; Mori TA; Beilin LJ; Watts GF J Pediatr; 2016 Mar; 170():315-6. PubMed ID: 26690851 [TBL] [Abstract][Full Text] [Related]
57. Efficacy of clinical diagnostic criteria for familial hypercholesterolemia genetic testing in Poland. Mickiewicz A; Chmara M; Futema M; Fijalkowski M; Chlebus K; Galaska R; Bandurski T; Pajkowski M; Zuk M; Wasag B; Limon J; Rynkiewicz A; Gruchala M Atherosclerosis; 2016 Jun; 249():52-8. PubMed ID: 27062410 [TBL] [Abstract][Full Text] [Related]
59. Screening and treatment of familial hypercholesterolemia - Lessons from the past and opportunities for the future (based on the Anitschkow Lecture 2014). Besseling J; Sjouke B; Kastelein JJ Atherosclerosis; 2015 Aug; 241(2):597-606. PubMed ID: 26115072 [TBL] [Abstract][Full Text] [Related]
60. Stress testing response in women heterozygous for familial hypercholesterolemia. Kolovou GD; Damaskos DS; Anagnostopoulou KK; Salpea KD; Dritsas A; Giannakopoulou V; Vasiliadis IK; Cokkinos DV Int J Cardiol; 2007 Oct; 122(1):96-7. PubMed ID: 17239976 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]